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The carbohydrate modification of serine and threonine residues with O-linked beta-
N -acetylglucosamine (O-GlcNAc) is ubiquitous and governs cellular processes ranging
from cell signaling to apoptosis.The O-GlcNAc modification along with other carbohydrate
modifications, including N-linked and O-linked glycans, glycolipids, and sugar polymers, all
require the use of the nucleotide sugar UDP-GlcNAc, the end product of the hexosamine
biosynthetic pathway (HBP). In this paper, we describe the biochemical consequences
resulting from perturbation of the O-GlcNAc pathway in C. elegans lacking O-GlcNAc
transferase and O-GlcNAcase activities. In ogt-1 null animals, steady-state levels of UDP-
GlcNAc/UDP-GalNAc and UDP-glucose were substantially elevated. Transcripts of genes
encoding for key members in the HBP (gfat-2, gna-2, C36A4.4) and trehalose metabolism
(tre-1, tre-2, tps-2) were elevated in ogt-1 null animals. While there is no evidence to sug-
gest changes in the profile of N-linked glycans in the ogt-1 and oga-1 mutants, glycans
insensitive to PNGase digestion (including O-linked glycans, glycolipids, and glycopoly-
mers) were altered in these strains. Our data support that changes in O-GlcNAcylation
alters nucleotide sugar production, overall glycan composition, and transcription of genes
encoding glycan processing enzymes. These data along with our previous findings that
disruption in O-GlcNAc cycling alters macronutrient storage underscores the noteworthy
influence this posttranslational modification plays in nutrient sensing.
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INTRODUCTION
Posttranslational modifications ranging from glycosylation to
phosphorylation play critical roles in biological processes includ-
ing protein localization, transcription, and cellular signaling [see
Ref. (1) and references therein]. The posttranslational modifica-
tion O-linked beta-N -acetyl glucosamine (O-GlcNAc) is ubiqui-
tous throughout the nucleus and cytoplasm modifying over 4000
protein substrates including nuclear pore and transcription com-
plexes, proteasomes, and kinases (2). The addition and removal
of O-GlcNAc to serine and threonine residues is governed by two
enzymes, O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA),
respectively (3). This dynamic cycling occurs faster than protein
turnover poising O-GlcNAc to act as a signaling molecule (4).
UDP-GlcNAc, the activated nucleotide sugar utilized by OGT, is
the end product of the hexosamine biosynthetic pathway (HBP).
A metabolite responsible for sensing the nutrient status of the
cell, UDP-GlcNAc is synthesized by a series of enzymes utiliz-
ing key metabolites including glucose, l-glutamine, acetyl-CoA,
and UTP (5). Perturbation of the HBP is linked with modulation
in insulin signaling and glucose toxicity [see Ref. (6) and refer-
ences therein]. Indeed, globally decreased levels of UDP-GlcNAc
can be profoundly damaging to mammals (7). The way in which
the HBP plays a role in the modulation of insulin signaling and
glucose toxicity is currently being defined with implications that
O-GlcNAcylation plays an important mechanistic role [see Ref.
(8) and references therein].
We previously demonstrated that C. elegans loss-of-function
ogt-1 and oga-1 animals have altered insulin signaling and
carbohydrate–fat metabolism (9). Importantly, ogt-1 and oga-1
null C. elegans are viable while loss of OGT and OGA activity
in higher eukaryotes yields embryonic lethality (10, 11). C. elegans
lacking OGT-1 activity exhibit no addition of O-GlcNAc to protein
serine and threonine residues and animals without OGA-1 activ-
ity lack the capacity to remove the modification. In order to better
understand the repercussions of impaired O-GlcNAc cycling in a
whole organism, we chose to define the way in which these pertur-
bations altered UDP-GlcNAc concentrations, glycan composition,
and transcription of important metabolic enzymes. Among the
most striking differences, we found that animals lacking OGT-1
or OGA-1 activities exhibit increases in UDP-HexNAc pools and
differences in their overall glycan compositions compared to wild
type (N2). Indeed, along with these changes, ogt-1 null animals
also show increased transcription of metabolic and HBP genes
suggesting that the animals are modulating or attempting to com-
pensate for the altered carbohydrate profiles. Although O-GlcNAc
cycling has been linked to nutrient sensing, we provide the first evi-
dence in a whole organism that O-GlcNAc plays an important role
in modulating nucleotide sugar utilization and the steady-state
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levels of transcripts encoding key HBP enzymes. We suggest that
O-GlcNAc acts as a rheostat to fine-tune evolutionarily conserved
components of C. elegans metabolism giving a defined model to
study how changes in O-GlcNAc may impact human health.
MATERIALS AND METHODS
C. ELEGANS AND BACTERIAL STRAINS AND MAINTENANCE
The following C. elegans strains were used in this study: N2 Bris-
tol (WT), ogt-1 (ok430), ogt-1 (tm1046), and oga-1 (ok1207). The
ogt-1 (ok430) and oga-1 (ok1207) strains were provided by the
C. elegans Gene Knockout Consortium (CGC, Oklahoma Medical
Research Foundation, Oklahoma City) and the ogt-1 (tm1046)was
provided by the National Bioresource Project of Japan. All strains
were backcrossed four times to N2 prior to use in experiments.
The presence of the deletion alleles was confirmed by nested PCR
primers as described by the CGC. The OP50 E. coli was cultured
without antibiotic at room temperature in Luria–Bertani (LB)
broth and plated on nematode growth media (NGM) plates or 2%
agarose-topped LB plates. NGM plates were made with tryptone
rather than peptone. C. elegans were maintained on NGM plates
supplemented with OP50 E. coli and animals were manipulated
using standard techniques (12, 13). Two percent agarose-topped
LB plates were used for RNA isolation experiments only.
ISOLATION OF NUCLEOTIDE SUGAR
C. elegans strains were grown in large quantities starting from
synchronous L1 stage and collected when animals reached the
gravid adult stage (after approximately 72 h incubation at room
temperature, 22°C). Animals were washed from NGM plates with
water, washed twice with water, counted, and purged by rocking
animals for 30 min in water at room temperature as previously
described (9). Animals were isolated by centrifugation and the
supernatant removed first by pipette and then by lyophilization.
To 8 mg lyophilized worms, 0.75 ml cold 0.5 N perchloric acid
was added. The suspension was vortexed vigorously for 20 s in
an ice bath followed by centrifugation at 15,000× g for 10 min at
4°C and the supernatant was collected. The remaining pellet was
extracted second time and the two supernatants was pooled. Two
hundred microliters of charcoal suspension (30 mg of Mallinck-
rodt charcoal/ml of 1 N perchloric acid) was added to the cold
supernatant and stirred vigorously in an ice bath. The activated
charcoal in acidic solution binds the nucleotide sugar and the sug-
ars are then released in the alkaline solution in the following steps.
After centrifugation at 15,000× g for 10 min at 4°C, the super-
natant was discarded. The charcoal pellet was eluted three times
with 750µL of a solution containing 50% ethanol+ 1% NH4OH.
The EtOH solutions were isolated, pooled, frozen, and lyophilized.
This experiment was performed in triplicate. Isolated sugars were
analyzed by high performance anion exchange chromatography
(HPAEC) with pulse amperometric detector (PAD) using a PA10
anion exchange column as described by Suriano et al. (14). Error
bars represent SD of an experiment done in triplicate and P val-
ues were calculated by an unpaired Student’s t -test. ns: P > 0.05;
*P < 0.05 compared to N2.
ISOLATION OF PNGase-SENSITIVE GLYCANS
Glycoprotein rich fractions were isolated from C. elegans at syn-
chronous L4 larval stage by procedures described by Cipollo
et al. (15, 16). Further processing was analogous to preparation
described in the aforementioned papers with minor modifica-
tions. Isolated glycoproteins were treated with l-1-tosylamido-
2-phenylethyl chloromethyl ketone trypsin for 4 h at 37°C in
50 mM ammonium bicarbonate, pH 8.5 buffer. The reaction was
stopped by boiling the samples twice for 10 min. The result-
ing peptides were isolated by acetone (80%) precipitation. N-
glycans were released from these glycopeptides by incubating with
PNGase A (Roche) and F (Prozyme) enzymes according to the
manufacturers’ protocols. PNGase-sensitive glycans were pooled
and purified by passing through LudgerClean™ EB10 Glycan
Cleanup Cartridge following the manufacturer’s protocol. Result-
ing glycans were hydrolyzed with 2 M TFA for 4 h at 100°C to
yield monosaccharides. Samples were evaporated to dryness and
resuspended in 100µL of deionized water. This evaporation and
resuspension was repeated twice with the last 100µL water sus-
pension passed through a cation exchange resin to remove amino
acids and peptides. A portion of this resulting monosaccharide-
containing solution was profiled by HPAEC-PAD as described
elsewhere (14, 17). To measure GalNAc and GlcNAc, the con-
centrations of monosaccharides galactosamaine (GalN) and glu-
cosamine (GlcN) were measured by HPAEC as, immediately fol-
lowing their release, the N -acetyl sugars undergo quantitative
deacetylation. Error bars represent SD of an experiment done
in triplicate, and P values were calculated by an unpaired Stu-
dent’s t -test. ns: P > 0.05; *P < 0.05; **P < 0.005; ***P < 0.0005
compared to N2.
ISOLATION OF RNA FROM L4 STAGE C. ELEGANS
OP50 grown on agarose coated LB plates were seeded with syn-
chronized L1 N2, ogt-1 (ok430), and oga-1 (ok1207) strains. Ani-
mals incubated at room temperature (22°C) were collected after
roughly 48 h when N2 animals reached a synchronous L4 stage.
Although animals were synchronous at L1, we noticed that ogt-1
(ok430) animals had a difference in growth rate and we accom-
modated by plating them on OP50 4 h prior to the other strains.
Collected L4 populations contained 97, 95, 80, and 60% L4 animals
in N2, oga-1, ogt-1 (tm1046), and ogt-1 (ok430) strains, respec-
tively. The remaining animals ranged from stages L1 to L3. C.
elegans were isolated from plates, thoroughly washed with water to
remove bacteria, and worm pellets were stored −80°C for further
use. RNA was isolated from each strain using a Qiagen RNAeasy
Mini kit and quantified spectrophotometrically as described in
Ref. (4, 18).
qRT-PCR ANALYSIS
RNA was treated with DNAse from Invitrogen to destroy con-
taminating genomic DNA in RNA sample (4, 18). SuperScript
III (Invitrogen) was used to produce cDNA according to man-
ufacturer’s protocols with random primer from Promega. Fol-
lowing cDNA synthesis, quantitative real-time PCR (qRT-PCR)
was performed using SYBR Green to quantitatively determine
gene expression. RNA treated without reverse transcriptase served
as the negative control. The experiment was performed in bio-
logical triplicate and samples were normalized to the control
gene act-4. qRT-PCR data were analyzed by the comparative C t
method, error bars represent SD, and P values were calculated by
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FIGURE 1 | O-GlcNAc cycling mutants exhibit increased
concentrations of nucleotide sugar. UDP-nucleotide sugars were
assessed by HPAEC-PAD detection. Compared to N2 animals, ogt-1
(ok430), ogt-1 (tm1046), and oga-1 (ok1207) animals have increased levels
of UDP-nucleotide sugar. Error bars represent SD of an experiment done in
triplicate. ns: P >0.05; *P <0.05 compared to N2.
an unpaired Student’s t -test. ns: P > 0.05; *P < 0.05; **P < 0.005;
***P < 0.0005 compared to N2.
GENE ACCESSION INFORMATION
Gene public name, Gene WormBase ID: ogt-1, K04G7.3, WBGene
00003858; oga-1, T20B5.3, WBGene00020596; gfat-2, F22B3.4,
WBGene00009035; gna-1, B0024.12, WBGene00001646; gna-2,
T23G11.2, WBGene00001647; C36A4.4, WBGene00007965; tre-1,
F57B10.7, WBGene00006607; tps-2, F19H8.1, WBGene00006603;
gsy-1, Y46G5A.31, WBGene00001793; Y73B6BL.4, WBGene00022
233; act-4, M03F4.2, WBGene00000066.
RESULTS
NUCLEOTIDE SUGAR LEVELS ARE INCREASED IN C. ELEGANS ogt-1
AND oga-1 MUTANTS
The C. elegans nucleocytoplasmic enzyme OGT-1 relies on a por-
tion of the UDP-GlcNAc pool to glycosylate serine and threonine
residues with O-GlcNAc. We sought to determine the upstream
consequences when either OGT-1 activity, or the activity of its
counterpart OGA-1, were absent in C. elegans. We initially pro-
filed activated nucleotide sugar concentrations by isolating the
nucleotide sugar pools, treating them with mild acid hydrol-
ysis, and profiling the freed monosaccharides by HPAEC-PAD
(Figure 1). We were intrigued to find that animals lacking either
OGT-1 or OGA-1 activity demonstrated increased pools of UDP-
glucose and ogt-1 animals had increased UDP-GlcNAc/UDP-
GalNAc (represented as UDP-HexNAc) pools. Loss of OGT-1
yielded animals with over a twofold increase in these nucleotide
sugars compared to N2 while oga-1 animals demonstrated a
more modest increase. Importantly, the increased nucleotide sugar
pool was similarly elevated in both C. elegans ogt-1 null alle-
les that we used throughout the paper to further support our
conclusions (Figure 1). Additional nucleotide sugars profiled
(GDP-mannose, GDP-fucose, and UDP-galactose) were present in
minimal amounts and their concentrations remained unchanged
in ogt-1 (ok430), ogt-1 (tm1046), and oga-1 (ok1207) animals
compared to N2 (data not shown).
FIGURE 2 | C. elegans lacking OGT-1 and OGA-1 activity show
increased GalN, GlcN, and Gal monosaccharides compared to N2
animals (B). Concentrations of monosaccharides galactosamaine (GalN)
and glucosamine (GlcN) were measured by HPAEC as, immediately
following their release, the N -acetyl sugars GalNAc and GlcNAc,
respectively, undergo quantitative deacetylation. No statistically different
changes were observed for the composition of PNGase A and F sensitive
glycans for O-GlcNAc cycling mutants when compared to N2 animals (A).
Error bars represent SD of an experiment done in triplicate. ns: P >0.05;
*P < 0.05; **P <0.005; ***P < 0.0005 compared to N2.
PNGase RESISTANT MONOSACCHARIDES ARE INCREASED IN ogt-1
NULL ANIMALS
UDP-GlcNAc is required for the production of a myriad of gly-
cans, which suggests that changes in its concentration may affect
glycan synthesis. Indeed, increased pools of UDP-GlcNAc have
been correlated with the production of tri- and tetra-antennary N-
glycans in mammary carcinoma cells (19). To determine whether
complex glycan synthesis was affected by deletion of the C. ele-
gans O-GlcNAc cycling enzymes, we assessed whole animal glycan
composition. Briefly, isolated N-glycans were released by PNGase
A and F, pooled, purified, and hydrolyzed with TFA. The resulting
monosaccharide concentrations were assessed by HPAEC-PAD.
Although ogt-1 animals exhibit over a twofold increase in UDP-
HexNAc levels compared to N2 (Figure 1), the released mono-
saccharides from N2, ogt-1 (ok430), ogt-1 (tm1046), and oga-1
(ok1207) animals’ N-glycans remain largely similar (Figure 2A).
Specifically, the ratio of mannose to GlcNAc suggests N-glycans
form normally in these mutants.
Glycan structures not cleaved by PNGase A and F include
O-linked glycans, glycolipids, and glycopolymers. To determine
whether the PNGase-insensitive glycans were altered in ogt-1 and
oga-1 null animals, the residual glycoprotein pellets were treated
with 2 M TFA and the freed sugar pools were assessed. The ogt-1
and oga-1 null animals exhibited up to 3.7-fold higher GalNAc,
GlcNAc, and galactose levels compared to N2 worms suggesting
structural changes in glycan composition for PNGase-insensitive
glycans when O-GlcNAc cycling is perturbed (Figure 2B).
GENES ENCODING ENZYMES INVOLVED IN UDP-GlcNAc SYNTHESIS
AND METABOLISM ARE PERTURBED IN O-GlcNAc CYCLING MUTANTS
With nucleotide sugar pools and PNGase-insensitive glycan struc-
tures affected by the loss of ogt-1 and oga-1, we hypothesized
that the transcription of genes encoding enzymes involved in
nucleotide sugar production and metabolism would be affected.
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FIGURE 3 |Transcripts of genes encoding key HBP enzymes are
elevated in ogt-1 null animals. Animals lacking OGT-1 activity show
increased transcripts of gfat-2, gna-2, and C36A4.4 genes while animals
lacking OGA-1 activity are not statistically different from N2. Error bars
represent SD of an experiment done in triplicate. ns: P >0.05; *P <0.05;
**P <0.005; ***P <0.0005 compared to N2.
To address this question, we examined the expression of key com-
ponents of the HBP as well as trehalose and glycogen metabolism
modules by qRT-PCR.
The following genes encode key enzymes in the HBP: gfat-2
(F22B3.4 encodes the HBP’s rate-liming glucosamine:fructose-6-
phosphate aminotransferase – GFAT-2), gna-2 (a glucosamine-6-
phosphate N -acetyltransferase), and C36A4.4 (the putative UDP-
GlcNAc pyrophosphorylase orthologous to human UAP1) (20).
Transcripts for gfat-2, gna-2, and C36A4.4 are all elevated in ogt-
1 (ok430) mutants while the transcript levels in oga-1 (ok1207)
mutants remain unchanged (Figure 3). Elimination of OGT-1, an
enzyme that utilizes a portion of the UDP-GlcNAc pool, affects
the transcription of genes required for the synthesis of the same
nucleotide sugar. This is not surprising as the HBP is exquisitely
sensitive to nucleotide sugar concentrations and we suggest that
gene transcription changes may be due to changes in feedback
inhibition within the HBP. It is possible that there are no changes
in HBP gene transcription for animals lacking OGA-1 activity as
OGT-1 can still actively use UDP-GlcNAc.
Our previous work identified that total amounts of glycogen
and trehalose, two important forms of energy storage, which can
be enzymatically broken down to glucose, were increased in ogt-
1 and oga-1 null animals (9). Here, we find that in comparison
to N2 animals, ogt-1 null animals exhibit increased transcription
for enzymes involved in trehalose and glycogen metabolism (tre-
1, tre-2, tps-2, and gsy-1) (Figure 4A). Interestingly, while ogt-1
(ok430) animals exhibit nearly twofold changes for all four genes,
the oga-1 (ok1207) animals exhibited no statistical changes from
N2 suggesting that changes in the ability of the animal to add
and remove the O-GlcNAc modification have different biological
consequences.
Triglyceride levels are significantly altered when OGT activity
is perturbed in mice and C. elegans (9, 10, 21). To better under-
stand our data showing 40–70% decreases in triglyceride levels
in O-GlcNAc cycling mutants (9, 10), we assessed the level of
FIGURE 4 |Transcripts of genes encoding enzymes critical for
metabolism are altered in C. elegans O-GlcNAc cycling mutants. ogt-1
(ok430) animals exhibit an increases in (A) tre-1, tre-2, tps-2, gsy-1, and
(B)Y73B6BL.4 while oga-1 (ok1207) animals show an increase in only
Y73B6BL.4. Error bars represent SD of an experiment done in triplicate. ns:
P >0.05; *P < 0.05; **P <0.005; ***P < 0.0005 compared to N2.
transcription of Y73B6BL.4, a gene encoding a phospholipase (22).
Indeed, this phospholipase increased over fourfold for both ogt-1
alleles and the oga-1 (ok1207) animals (Figure 4B).
DISCUSSION
Cellular signaling depends on a series of protein posttranslational
modifications working in concert to define protein localization,
enzyme activity, and recognition events. Modifications ranging
from glycosylation to phosphorylation are among the most widely
recognized and defined posttranslational modifications with pro-
tein glycosylation being the most heterogeneous. The HBP pro-
duces a nutrient-sensitive nucleotide sugar, UDP-GlcNAc, that
is utilized by glycosyltransferases in endo-membrane organelles
(Golgi and endoplasmic reticulum) (23) as well as enzymes in
the nucleus and cytoplasm (Figure 5). Optimal levels of UDP-
GlcNAc are required for maintenance of cellular homeostasis
in mammals with profound consequences including embryonic
lethality resulting from loss of the nucleotide sugar synthesis (7,
24). The importance of this nucleotide sugar is evolutionarily con-
served as loss or knockdown of enzymes required for synthesis of
UDP-GlcNAc yields phenotypes including lethality in C. elegans
(25–29).
Endo-membrane enzymes utilize UDP-GlcNAc to initiate N-
glycosylation and further glycan branching (30). A portion of the
UDP-GlcNAc pool is also used by OGT to glycosylate a myriad of
nucleocytoplasmic targets ultimately influencing proteins’ local-
ization, activity, and/or folding [see Ref. (8, 31) and references
therein]. Perturbation of O-GlcNAc cycling yields a wide range of
biological consequences; indeed, OGT and OGA are essential for
viability in mice and other higher eukaryotes (11, 32). In viable C.
elegans animals with loss-of-function of ogt-1 and oga-1 genes, we
note altered carbohydrate and lipid metabolism as well as severely
deregulated insulin signaling (9, 10, 33). Furthermore, we found
that C. elegans animals with altered O-GlcNAc cycling have strik-
ing changes in fertility and reproductive timing during glucose
stress suggesting that O-GlcNAc acts as a buffer to sense glucose
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FIGURE 5 | Interference with the addition of O-GlcNAc (1) results in
elevation of UDP-GlcNAc and UDP-GalNAc (UDP-HexNAc) levels (2).
Compensatory metabolic changes include increased flux into some complex
glycans (3). Feedback inhibition of GFAT (4) is insufficient to fully normalize
UDP-HexNAc levels in the absence of OGT-1. In addition, with increased
nucleotide sugar pools, there are changes in upstream complex sugar levels
(5) and decreased macronutrient storage (6). These changes in cellular
nucleotide sugar pools are associated with altered transcriptional regulation of
genes encoding hexosamine biosynthetic pathway and macronutrient storage
enzymes (see text). Metabolite levels are increased (green), decreased (red),
remain the same (gray), or were untested (black). Glc, glucose; G-6-P,
glucose-6-phosphate; F-6-P, fructose-6-phosphate; GluN, glutamine; GlcN-6-P,
glucosamine-6-phosphate; GlcNAc-6-P, N -acetylglucosamine-6-P; GlcNAc-1-P,
N -acetylglucosamine-1-phosphate; acetyl-CoA, acetyl coenzyme A.
availability (34). The work herein details the way in which per-
turbations in O-GlcNAc cycling influences changes in overall C.
elegans carbohydrate composition as well as the transcription of
key metabolic enzymes.
Our first efforts focused on identifying the ways in which
changes to O-GlcNAc cycling affected nucleotide sugar concen-
trations and overall cellular carbohydrate structure. We noted that
UDP-Glc and UDP-HexNAc (a combination of UDP-GlcNAc and
UDP-GalNAc) were elevated 1.5- to 3-fold in the ogt-1 and oga-
1 animals (Figure 1). Importantly, other nucleotide sugars such
as GDP-mannose were not altered suggesting specific changes
to the pool of activated sugars directly downstream of glucose
metabolism. The elevation of UDP-Glc and UDP-HexNAc in both
O-GlcNAc cycling mutants intrigued us. It is clear that in ogt-1
loss-of-function animals, the UDP-GlcNAc pools would be ele-
vated: the animals no longer utilize the activated nucleotide sugar
to produce the O-GlcNAc PTM. Conversely, in animals that lack
OGA-1 activity, while OGT-1 remains capable of utilizing UDP-
GlcNAc to glycosylate protein substrates, the cycling of the PTM
is likely altered and may influence the turnover of the nucleotide
sugar pool. We speculate that this may explain the modest changes
in nucleotide sugar concentrations and alterations in PNGAse-
insensitive glycans but yield milder effects on the transcription of
HBP members.
We hypothesized that among the consequences for even mod-
est changes in activated nucleotide sugar pools, animals lacking
ogt-1 and oga-1 would exhibit changes in N-glycan structures.
Indeed, N-glycan structures have been shown to be ultrasensitive
to UDP-GlcNAc concentration (19). We were, thus, surprised to
find that N-glycan monosaccharide composition in both ogt-1 and
oga-1 animals was indistinguishable from N2 animals (Figure 2A).
These data suggest that the C. elegans mutants lacking O-GlcNAc
cycling to have no global defect in constructing glycans sensitive to
PNGase F and A. Interestingly, we found that glycans resistant to
PNGase A or F (heterogeneous O-linked glycans, glycolipids, and
glycan polymers) exhibited marked increases in galactose, GalNAc,
and GlcNAc in both ogt-1 and oga-1 animals (Figure 2B). Recent
work catalogs 14 types of mucin type O-linked glycans in the
C. elegans WT strain with changes to O-linked glycans in another
glycosyltransferase mutant (35). Future work will define the struc-
tural changes found in ogt-1 and oga-1 null animals’ PNGase resis-
tant glycans. The compiled data suggest that the inability to add
and remove O-GlcNAc on nuclear and cytoplasmic targets has far-
reaching cellular affects affecting global glycosylation. These effects
are likely to be pleiotropic and result from changes in transcription,
metabolic flux, signaling, or direct enzyme activation. Among the
reasons for these changes could be both direct and indirect pertur-
bation of enzymes required for nucleotide sugar synthesis or the
speed at which glycosylated proteins traffic through the secretory
pathway (36).
With evidence suggesting that O-GlcNAc cycling is a key player
in sensing cell nutrient status from our work and the work of others
[see Ref. (31, 37) and references therein], we next hypothesized that
the transcription of critical players in the HBP would be altered in
the ogt-1 and oga-1 animals. The first, and rate limiting, enzyme
of the HBP is GFAT, which is responsible for the conversion of
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fructose-6-phosphate to glucosamine-6-phosphate (Figure 5). To
note, the activity of GFAT is modulated by UDP-GlcNAc itself
through a feedback mechanism to reduce HBP flux (38). Two
glucosamine-6-phosphate N -acetyltransferases (gna-1 and gna-
2) are required for an intermediary step in the HBP, and C36A4.4
is the presumptive pyrophosphorylase required for the last step in
the synthesis of UDP-GlcNAc. We examined the expression levels
for gfat-2, gna-1, gna-2, and C36A4.4 and noted that only in ogt-1
mutants were there statistically significant changes in transcrip-
tion for three of the four transcripts (Figure 3). Although feedback
inhibition should occur in ogt-1 animals due to increased UDP-
HexNAc levels, it is insufficient to normalize the nucleotide sugar
pool with increased gfat-2 transcription. Moreover, these findings
were surprising as PNGase-insensitive glycans were altered in both
mutants suggesting a complex interplay between nutrient flux and
appropriate substrate O-GlcNAc modification. (37).
Given that the O-GlcNAc cycling mutants exhibit variations
in activated nucleotide sugar pools, changes in glycosylation
(Figures 1 and 2), and increased glycogen and trehalose storage
(9), we next assessed the levels of transcription for genes encoding
enzymes involved in trehalose and glycogen metabolism.C. elegans
encodes four putative glycoside hydrolases – enzymes responsible
for catalyzing the conversion of trehalose to glucose – including
tre-1 and tre-2. tps-2 encodes for one of two enzymes responsi-
ble for trehalose-6-phosphate synthesis and gsy-1 is ortholog to
the human glycogen synthase 1. All four of these transcripts were
found to be elevated in ogt-1 mutants while the levels remain
unchanged in oga-1 animals (Figure 4). These findings are con-
sistent with our previous reports suggesting major changes in
trehalose and glycogen metabolism upon genetic interference with
O-GlcNAc cycling. The present findings suggest that these changes
are associated with increased metabolic flux to produce UDP-Glc
and with transcriptional changes in the transcripts encoding the
relevant enzymes mediating interconversion.
Triglyceride levels have been shown to correlate with perturba-
tions in O-GlcNAc cycling in both mice and C. elegans (9, 10, 21)
and free fatty acids, usually derived from triglycerides or phospho-
lipids, are known to be potent HBP modulators (39). Our previous
work demonstrated that triglyceride levels are decreased by 70%
in ogt-1 and 40% in oga-1 compared to N2 (9). These data suggest
that either the production of triglycerides was hampered or their
hydrolysis was increased. To test whether triglycerides are catabo-
lized more rapidly in the O-GlcNAc cycling mutants, we assessed
the transcriptional expression of Y73B6BL.4, a gene encoding for
a phospholipase. We noted a significant increase in transcription
for Y73B6BL.4 in both O-GlcNAc cycling mutants supporting that
the decrease in triglyceride levels for both ogt-1 and oga-1 animals
is likely associated with increased hydrolysis.
Perturbations of OGA activity in cell culture (40–42), loss of
OGA-1 activity in C. elegans (9, 10), and OGT overexpression
in mouse liver or fat promotes insulin resistance (43). Further-
more, loss of OGT-1 yields insulin sensitivity in C. elegans and
altered lipid and carbohydrate metabolism (9, 10). Together, these
data support a strong role for O-GlcNAc in insulin signaling
metabolism maintenance. Our results reveal that loss of ogt-1
and oga-1 changes the nucleotide sugar pools and the production
of PNGase-insensitive glycans. These changes along with altered
transcriptional expression of genes encoding key HBP and meta-
bolic enzymes in ogt-1 null animals suggest that the addition of
O-GlcNAc to appropriate target proteins is critical for appropri-
ate HBP flux. Additional roles of OGT, including its non-catalytic
role in protein–protein interactions (44), could also influence this
signaling paradigm. We propose that with O-GlcNAc cycling pro-
foundly affecting the HBP, C. elegans is an excellent model to
studying metabolic changes associated with insulin signaling in
viable ogt-1 and oga-1 null alleles (Figure 5). Using C. elegans ogt-
1 and oga-1 animals, we will be able to further define the molecular
details of the HBP’s role in insulin resistance.
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